NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
GeneNews Ltd. (TSE: GEN)
GEN Technical Analysis
5
As on 31st Oct 2017 GEN Share Price closed @ 0.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.25 & Strong Sell for SHORT-TERM with Stoploss of 0.10 we also expect STOCK to react on Following IMPORTANT LEVELS. |
GEN Share Price
Open | 0.08 | Change | Price | % |
High | 0.08 | 1 Day | 0.00 | 0.00 |
Low | 0.08 | 1 Week | 0.00 | 0.00 |
Close | 0.08 | 1 Month | -0.01 | -11.11 |
Volume | 138700 | 1 Year | -0.39 | -82.98 |
52 Week High 0.53 | 52 Week Low 0.08 |
TSE Canada Most Active Stocks
BIN | 41.40 | -1.62% |
LSG | 2.08 | 8.33% |
TBE | 0.03 | 0.00% |
ECA | 15.09 | 4.43% |
SC | 60.83 | -0.44% |
PRE | 0.64 | 0.00% |
ELD | 1.62 | -6.90% |
MFC | 25.94 | -0.04% |
CPG | 10.61 | 4.53% |
BBD-B | 2.73 | -1.09% |
TSE Canada Top Gainers Stocks
TSE Canada Top Losers Stocks
GEN Daily Charts |
GEN Intraday Charts |
Whats New @ Bazaartrend |
GEN Free Analysis |
|
GEN Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 0.08 |
RESISTANCE | 0.08 |
RESISTANCE | 0.08 |
RESISTANCE | 0.08 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
GEN Target for Month January
4th UP TARGET | 0.12 |
3rd UP TARGET | 0.11 |
2nd UP TARGET | 0.1 |
1st UP TARGET | 0.09 |
1st DOWN TARGET | 0.07 |
2nd DOWN TARGET | 0.06 |
3rd DOWN TARGET | 0.05 |
4th DOWN TARGET | 0.04 |
GEN Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
GEN Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
GeneNews Ltd. ( TSE Canada Symbol : GEN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
GEN Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Healthcare | |
Industry | Medical Laboratories & Research | |
Offical website | > echo $website ; ?> |
GEN Address
![]() |
445 Apple Creek Boulevard Suite 220 Markham, ON L3R 9X7 Canada Phone: 905-739-2030 Fax: 905-739-2031 |
GEN Latest News
GEN Business Profile
GeneNews Limited, a molecular diagnostics company, focuses on the development and application of functional genomics to enable early diagnosis and personalized health management based on disease specific biomarkers. Its principal platform technology, the Sentinel Principle, detects and stages various diseases or medical conditions from a blood sample. The company is applying the Sentinel Principle in the areas of cancer, arthritis, cardiovascular diseases, and neurological disorders. Its lead product includes ColonSentry, a blood-based molecular test to aid physicians in determining an individualÂ’s risk of having colorectal cancer. The company was formerly known as ChondroGene Limited and changed its name to GeneNews Limited in October 2006. GeneNews Limited was founded in 1998 and is headquartered in Markham, Canada.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service